Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
clinical trial data
Pharma
Neurocrine's Ingrezza misses in cerebral palsy trial
Just days after an upbeat R&D event, Neurocrine Biosciences has found itself having to report a phase 3 failure.
Angus Liu
Dec 23, 2025 10:20am
Gilead's single-tablet HIV combo passes 2nd late-stage test
Dec 16, 2025 9:15am
Pfizer details Tukysa's 1st-line data in HER2 breast cancer
Dec 10, 2025 8:15am
With site 'irregularities,' BMS delays key Cobenfy readout
Dec 3, 2025 10:14am
Akeso details ivonescimab's 1st overall survival win
Nov 7, 2025 11:30am
Keytruda, Padcev cut risk of death by 50% in MIBC patient subset
Oct 18, 2025 10:30am
